Old Web
English
Sign In
Acemap
>
authorDetail
>
C.E. Ortmann
C.E. Ortmann
Novartis
Medicine
Physical therapy
Diabetes mellitus
Internal medicine
Zoledronic acid
4
Papers
57
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Secukinumab effects on disease burden, patient needs and benefits, and treatment satisfaction in patients with plaque psoriasis across European regions: Patient perspective data from the PROSE study
2021
Journal of The European Academy of Dermatology and Venereology
N. da Silva
Rachel Sommer
C.E. Ortmann
Piotr Jagiello
T. Bachhuber
Matthias Augustin
Show All
Source
Cite
Save
Citations (0)
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III study.
2020
Journal of Endocrinological Investigation
Andrea Z. LaCroix
Marcello D. Bronstein
Jochen Schopohl
T. Delibasi
Roberto Salvatori
Yixue Li
Ariel R Barkan
N. Suzaki
Libuse Tauchmanova
C.E. Ortmann
Shoba Ravichandran
Stephan Petersenn
Rosario Pivonello
Show All
Source
Cite
Save
Citations (5)
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis.
2007
Osteoporosis International
Jean-Pierre Devogelaer
Jacques P. Brown
P. Burckhardt
Pierre J. Meunier
Stefan Goemaere
Kurt Lippuner
Jean-Jacques Body
Göran Samsioe
Dieter Felsenberg
T. Fashola
Liuska Sanna
C.E. Ortmann
Ulrich Trechsel
Joel S. Krasnow
Erik Fink Eriksen
Patrick Garnero
Show All
Source
Cite
Save
Citations (51)
Zoledronic acid safety and efficacy over 5 years in postmenopausal osteoporosis
2006
Osteoporosis International
Jean-Pierre Devogelaer
P. Burckhardt
Pierre J. Meunier
Jean-Marc Kaufman
Kurt Lippuner
Jean-Jacques Body
Göran Samsioe
Dieter Felsenberg
Jacques P. Brown
Patrick Garnero
L. Sanna
C.E. Ortmann
Joel S. Krasnow
Erik Fink Eriksen
T. F. Fashola
Ulrich Trechsel
Show All
Source
Cite
Save
Citations (1)
1